21.59
+0.09
+(0.42%)
At close: April 15 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 427,226 | 13 |
| Sales | 156,563 | 8 |
| Net Shares Purchased (Sold) | 270,663 | 21 |
| Total Insider Shares Held | 4.52M | -- |
| % Net Shares Purchased (Sold) | 6.40% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| FORDYCE MARSHALL Chief Executive Officer | Sale at price 27.55 - 28.32 per share. | Direct | 546,914 | Feb 26, 2025 |
| TURNER WILLIAM DONALD Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 18, 2025 |
| FORDYCE MARSHALL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 18, 2025 |
| YOUNG JOSEPH R Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 18, 2025 |
| GRANT SEAN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 18, 2025 |
| BRENNER ROBERT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 18, 2025 |
| FORDYCE MARSHALL Chief Executive Officer | Sale at price 41.53 - 42.03 per share. | Direct | 730,535 | Jan 8, 2025 |
| FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 50,694 | Jan 8, 2025 |
| FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 217,726 | Dec 19, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Sale at price 41.33 - 44.03 per share. | Direct | 753,680 | Dec 18, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Sale at price 46.91 - 47.65 per share. | Direct | 821,523 | Dec 11, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 50,694 | Dec 11, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Sale at price 47.05 - 49.00 per share. | Direct | 929,560 | Nov 25, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 56,126 | Nov 25, 2024 |
| CARTER JASON S Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 18, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Sale at price 49.00 - 51.20 per share. | Direct | 1,516,037 | Nov 13, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 88,714 | Nov 13, 2024 |
| SEIDENBERG BETH C Director | Sale at price 48.01 - 49.54 per share. | Direct | 720,493 | Oct 28, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Sale at price 39.80 - 42.00 per share. | Direct | 782,610 | Oct 23, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 56,126 | Oct 23, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Sale at price 38.08 - 38.83 per share. | Direct | 597,568 | Oct 9, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 45,262 | Oct 9, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Sale at price 45.42 - 47.06 per share. | Direct | 1,064,809 | Sep 25, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 66,988 | Sep 25, 2024 |
| SEIDENBERG BETH C Director | Sale at price 42.00 - 42.31 per share. | Indirect | 696,233 | Sep 19, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Sale at price 37.31 - 37.78 per share. | Direct | 585,934 | Sep 11, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 45,262 | Sep 11, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Sale at price 36.80 - 37.54 per share. | Direct | 1,117,140 | Aug 28, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 45,262 | Aug 28, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Sale at price 39.76 per share. | Direct | 575,425 | Aug 21, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Sale at price 37.56 per share. | Direct | 586,927 | Aug 14, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.90 per share. | Direct | 45,262 | Aug 14, 2024 |
| YOUNG JOSEPH R Officer | Sale at price 42.17 - 43.03 per share. | Direct | 1,304,435 | May 16, 2024 |
| YOUNG JOSEPH R Officer | Conversion of Exercise of derivative security at price 3.94 - 7.87 per share. | Direct | 194,911 | May 16, 2024 |
| YOUNG JOSEPH R Officer | Sale at price 40.00 per share. | Direct | 228,560 | Apr 10, 2024 |
| GRANT SEAN Chief Financial Officer | Sale at price 38.12 - 40.06 per share. | Indirect | 4,689,722 | Apr 3, 2024 |
| GRANT SEAN Chief Financial Officer | Conversion of Exercise of derivative security at price 14.87 per share. | Direct | 1,484,442 | Apr 3, 2024 |
| KATABI MAHA Director | Sale at price 40.50 - 46.18 per share. | Indirect | 34,099,583 | Mar 25, 2024 |
| KATABI MAHA Director | Purchase at price 31.00 per share. | Indirect | 4,999,990 | Jan 30, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 16, 2024 |
| YOUNG JOSEPH R Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 16, 2024 |
| GRANT SEAN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 16, 2024 |
| COMMODORE CAPITAL LP Beneficial Owner of more than 10% of a Class of Security | Sale at price 18.00 per share. | Indirect | 18,900,000 | Jan 10, 2024 |
| FORDYCE MARSHALL Chief Executive Officer | Conversion of Exercise of derivative security at price 2.32 - 2.90 per share. | Direct | 38,854 | Dec 29, 2023 |
| GRANT SEAN Chief Financial Officer | Stock Gift at price 0.00 per share. | Indirect | 0 | Dec 20, 2023 |
| CURLEY JOANNE Officer | Sale at price 16.66 per share. | Direct | 24,817 | Aug 21, 2023 |
| FORDYCE MARSHALL Chief Executive Officer | Sale at price 16.66 per share. | Direct | 86,779 | Aug 21, 2023 |
| LIN CELIA Officer | Sale at price 16.65 per share. | Direct | 24,816 | Aug 21, 2023 |
| YOUNG JOSEPH R Officer | Conversion of Exercise of derivative security at price 3.94 per share. | Direct | 39,396 | Jul 5, 2023 |
| GRANT SEAN Chief Financial Officer | Purchase at price 16.60 per share. | Indirect | 83,000 | Jun 23, 2023 |
Related Tickers
PTGX Protagonist Therapeutics, Inc.
46.95
+4.26%
MLTX MoonLake Immunotherapeutics
36.77
+2.85%
APGE Apogee Therapeutics, Inc.
32.85
-1.29%
TRVI Trevi Therapeutics, Inc.
6.20
+4.20%
AKRO Akero Therapeutics, Inc.
38.08
+1.28%
EWTX Edgewise Therapeutics, Inc.
13.02
+5.60%
IDYA IDEAYA Biosciences, Inc.
16.98
-0.76%
CYTK Cytokinetics, Incorporated
38.56
-3.14%
VRDN Viridian Therapeutics, Inc.
12.80
-3.76%
RNA Avidity Biosciences, Inc.
26.68
-0.85%